Abstract:Phage-encoded anti-CRISPR (Acr) proteins inhibit CRISPR-Cas systems to allow phage replication and lysogeny maintenance. Most of the Acrs characterized to date are stable stoichiometric inhibitors, and while enzymatic Acrs have been characterized biochemically, little is known about their potency, specificity, and reversibility. Here, we examine AcrIF11, a widespread phage and plasmid-encoded ADP-ribosyltransferase (ART) that inhibits the Type I-F CRISPR-Cas system. We present an NMR structure of an AcrIF11 homolog that reveals chemical shift perturbations consistent with NAD (cofactor) binding. In experiments that model both lytic phage replication and MGE/lysogen stability under high targeting pressure, AcrIF11 is a highly potent CRISPR-Cas inhibitor and more robust to Cas protein level fluctuations than stoichiometric inhibitors. Furthermore, we demonstrate that AcrIF11 is remarkably specific, predominantly ADP-ribosylating Csy1 when expressed in P. aeruginosa. Given the reversible nature of ADP-ribosylation, we hypothesized that ADPr eraser enzymes (macrodomains) could remove ADPr from Csy1, a potential limitation of PTM-based CRISPR inhibition. We demonstrate that diverse macrodomains can indeed remove the modification from Csy1 in P. aeruginosa lysate. Together, these experiments connect the in vitro observations of AcrIF11's enzymatic activity to its potent and specific effects in vivo, clarifying the advantages and drawbacks of enzymatic Acrs in the evolutionary arms race between phages and bacteria.

Structural and biochemical insights into the mechanism of the anti-CRISPR protein AcrIE3

Structural and Mechanistic Insight into CRISPR-Cas9 Inhibition by Anti-CRISPR Protein AcrIIC4Hpa

Mechanistic insights into the inhibition of the CRISPR-Cas surveillance complex by anti-CRISPR protein AcrIF13

Mechanism of inhibition of CRISPR-Cas9 by anti-CRISPR protein AcrIIC1

Inhibition mechanisms of CRISPR-Cas9 by AcrIIA25.1 and AcrIIA32

Inhibitory mechanism of CRISPR-Cas9 by AcrIIC4

Structural basis of Cas3 inhibition by the bacteriophage protein AcrF3

Cas9 Allosteric Inhibition by the Anti-CRISPR Protein AcrIIA6

Structural insights into the inactivation of the type I-F CRISPR-Cas system by anti-CRISPR proteins

Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type IIC Anti-CRISPR Proteins

Inhibition of CRISPR-Cas9 ribonucleoprotein complex assembly by anti-CRISPR AcrIIC2

Anti-CRISPR AcrIIC5 is a dsDNA mimic that inhibits type II-C Cas9 effectors by blocking PAM recognition

AcrIIC4 inhibits type II-C Cas9 by preventing R-loop formation

Structural basis of CRISPR-SpyCas9 inhibition by an anti-CRISPR protein

Structural and mechanistic insights into inhibition of the type I-F CRISPR-Cas surveillance complex by AcrIF4

Molecular Basis for Inhibition of Type Iii-B Crispr-Cas by an Archaeal Viral Anti-Crispr Protein

Computational design of anti-CRISPR proteins with improved inhibition potency and expanded specificity

The novel anti-CRISPR AcrIIA22 relieves DNA torsion in target plasmids and impairs SpyCas9 activity

Anti-CRISPR Protein AcrIF4 Inhibits the Type I-F CRISPR-Cas Surveillance Complex by Blocking Nuclease Recruitment and DNA Cleavage

AcrIF11 is a potent CRISPR-specific ADP-ribosyltransferase encoded by phage and plasmid

Insights into the Dual Functions of AcrIF14 During the Inhibition of Type I-F CRISPR–Cas Surveillance Complex